Skip to content

A program of International Vaccine Access Center by Johns Hopkins Bloomberg School of Public Health

Value of Immunization Compendium of Evidence

Home
Evidence Briefs
Knowledge Hub
Advocacy
Vaccine Resources
About VoICE

Estimating the cost-effectiveness of an infant 13-valent pneumococcal conjugate vaccine national immunization program in China

Post navigation

← The impact and cost-effectiveness of controlling cholera through the use of oral cholera vaccines in urban Bangladesh: a disease modeling and economic analysis

Access to childhood immunization services and its determinants among recent and settled migrants in Delhi, India →

VoICE is a project of the International Vaccine Access Center (IVAC) at the Johns Hopkins Bloomberg School of Public Health, and is made possible with support from the Bill & Melinda Gates Foundation. We thank the many partners who have contributed their time, energy and expertise to VoICE.

Learn More About IVAC
Contact Us

© 2024 The International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health. All rights reserved

Translation Disclaimer